Dr. Parmar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit Street
Boston, MA 02114
Summary
- Dr. Gaurav Parmar is a vascular medicine specialist at Massachusetts General Hospital and an Instructor of Medicine at Harvard Medical School. He serves as the Director of Vascular Medicine Outcomes Research, the Program Director of the Vascular Medicine Fellowship, and the Vascular Medicine Lead for the MGH Limb Evaluation, Assessment, and Preservation Program (LEAPP) at the MGH Peripheral Artery Disease (PAD) Center. Additionally, Dr. Parmar is the Interim Medical Director of VASCORE, the Vascular Imaging Core Laboratory at MGH, and Co-Medical Director of the MGH Anticoagulation Management Service. He is board-certified in Vascular Medicine by the American Board of Vascular Medicine. Dr. Parmar frequently presents at national and regional conferences, and he is the author of numerous publications, including book chapters and peer reviewed-publications, and serves as a reviewer for a variety of scientific journals, including the Vascular Medicine, official journal of the Society for Vascular Medicine. Dr Parmar has received multiple honors, including both teaching and residence awards. He is a Fellow of the Society for Vascular Medicine (FSVM), and the American College of Cardiology (FACC). He has served as a chair of the education committee of the Society for Vascular Medicine.
Dr. Parmar's research focuses on the epidemiology, outcomes, and disparities in cardiovascular diseases, particularly PAD. His significant contributions include demonstrating the benefits of statin therapy in PAD patients undergoing revascularization, improving limb salvage and mortality outcomes, which was featured in 50 Landmark Papers Every Vascular and Endovascular Surgeon Should Know (CRC Press, 2020). His recent work includes studies on high ankle-brachial index and long-term mortality, the impact of PAD and polyvascular disease in end-stage kidney disease and racial disparities in mortality rates over a 20-year period in individuals with PAD.
Education & Training
- Massachusetts General HospitalFellowship, Vascular Medicine, 2019
- University of Alabama at BirminghamMPH, Epidemiology, 2008
- Government Med Coll BhavnagarClass of 2005
Certifications & Licensure
- CA State Medical License 2015 - 2026
- HI State Medical License 2022 - 2026
- MA State Medical License 2017 - 2026
- ME State Medical License 2023 - 2026
- MO State Medical License 2014 - 2026
- NY State Medical License 2017 - 2026
- AL State Medical License 2014 - 2025
- American Board of Family Medicine Family Medicine
- Join now to see all
Publications & Presentations
PubMed
- Pulmonary Embolism in Patients with End-Stage Kidney Disease Starting Dialysis.Kunal N Patel, Wan-Chi Chan, Vivek Bhat, Monil M Majmundar, Harsh Mehta
JAMA Network Open. 2025-03-03 - High ankle-brachial index participants experienced similar long-term mortality as peripheral artery disease in a national sample of community-dwelling adults.Gaurav M Parmar, Rajasekhar Tanikella, Kamal Gupta, Andrew B Dicks, Rahul Sakhuja
Journal of Vascular Surgery. 2024-10-01 - 2 citationsDiagnosis of Pulmonary Embolism: A Review of Evidence-Based Approaches.Sneha E Thomas, Ido Weinberg, Robert M Schainfeld, Kenneth Rosenfield, Gaurav M Parmar
Journal of Clinical Medicine. 2024-06-26
Professional Memberships
- Member
- Society for Vascular MedicineMember
- American Public Health AssociationMember
- International Society on Thrombosis and HemostasisMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: